KannaLife Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • NPTX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.05
  • (As of Friday Closing)

KannaLife General Information

Description

Neuropathix Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from our proprietary synthetic cannabinoid derivatives platform potentially useful for a broad range of inflammatory and neuropathic pain-related diseases.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
PINX
Primary Office
  • 3805 Old Easton Road
  • Pennsylvania Biotechnology Center
  • Doylestown, PA 18902
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KannaLife Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.04 $0.04 - $0.81 $4.4M 88M 56.3K -$0.05

KannaLife Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 12,280 12,012 323,438
Revenue 32 0 126 174
EBITDA (3,678) (3,597) (3,298) 1,774
Net Income (4,250) (4,537) (3,444) 937
Total Assets 161 260 223 3,023
Total Debt 1,719 1,664 1,076 1,162
Public Fundamental Data provided by Morningstar, Inc. disclaimer

KannaLife Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KannaLife‘s full profile, request access.

Request a free trial

KannaLife Executive Team (5)

Name Title Board Seat Contact Info
Dean Petkanas Co-Founder, Chairman & Chief Executive Officer
Mark Corrao Chief Financial Officer
Thomas Kikis Co-Founder, Chief Communications Officer & Board Member
William Kinney Ph.D Chief Scientific Officer
You’re viewing 4 of 5 executive team members. Get the full list »

KannaLife Board Members (5)

Name Representing Role Since
0000 00000000 KannaLife Co-Founder, Chairman & Chief Executive Officer 000 0000
000000 00000 00.0 Medical Marijuana Board Member 000 0000
000000 00000 KannaLife Co-Founder, Chief Communications Officer & Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

KannaLife Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KannaLife Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KannaLife‘s full profile, request access.

Request a free trial

KannaLife Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 25-Jul-2018 000000000000000000 Application Software 0000 00000000
To view KannaLife’s complete acquisitions history, request access »